These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 35115348)
1. Study protocol of the ACCESS trial: a randomised trial to evaluate the effectiveness of human papillomavirus testing by self-sampling in cervical cancer screening uptake and precancer detection. Fujita M; Shimazu M; Nagashima K; Suzuki M; Tauchi I; Sakuma M; Yamamoto S; Shozu M; Hanaoka H; Tsuruoka N; Kasai T; Hata A BMJ Open; 2022 Feb; 12(2):e049803. PubMed ID: 35115348 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of self-sampling human papillomavirus test on precancer detection and screening uptake in Japan: The ACCESS randomized controlled trial. Fujita M; Nagashima K; Shimazu M; Suzuki M; Tauchi I; Sakuma M; Yamamoto S; Hanaoka H; Shozu M; Tsuruoka N; Kasai T; Hata A Int J Cancer; 2024 Sep; 155(5):905-915. PubMed ID: 38648390 [TBL] [Abstract][Full Text] [Related]
3. Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Māori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening. Brewer N; Bartholomew K; Maxwell A; Grant J; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Cunningham C; Douwes J; Potter JD BMC Cancer; 2019 Dec; 19(1):1198. PubMed ID: 31815615 [TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus-based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial. Gottschlich A; Gondara L; Smith LW; Cook D; Martin RE; Lee M; Peacock S; Proctor L; Stuart G; Krajden M; Franco EL; van Niekerk D; Ogilvie G Int J Cancer; 2022 Sep; 151(6):897-905. PubMed ID: 35460070 [TBL] [Abstract][Full Text] [Related]
5. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739 [TBL] [Abstract][Full Text] [Related]
6. Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology. Zehbe I; Jackson R; Wood B; Weaver B; Escott N; Severini A; Krajden M; Bishop L; Morrisseau K; Ogilvie G; Burchell AN; Little J BMJ Open; 2016 Oct; 6(10):e011754. PubMed ID: 27855089 [TBL] [Abstract][Full Text] [Related]
7. Combined incentive actions, focusing on primary care professionals, to improve cervical cancer screening in women living in socioeconomically disadvantaged geographical areas: a study protocol of a hybrid cluster randomised effectiveness and implementation trial- RESISTE. Hassine A; Antoni G; Fender M; Slama K; Léandri FX; Fanon JL; Auvray C; Jaffar Bandjee MC; Traversier N; Fagour L; Rochaix L; Fiorina C; Pourette D; Opigez E; Dumont A; Bardou M; Study Group R BMJ Open; 2022 Nov; 12(11):e065952. PubMed ID: 36418118 [TBL] [Abstract][Full Text] [Related]
8. Mailing human papillomavirus self-sampling kits to women under-screened for cervical cancer improved detection in cervical cancer screening in a general population study in Japan. Nishimura Y; Matsuura M; Terada N; Nagao S; Shimada H; Isoyama K; Tamate M; Iwasaki M; Saito T BMC Public Health; 2023 Mar; 23(1):473. PubMed ID: 36906527 [TBL] [Abstract][Full Text] [Related]
9. A Randomized Clinical Trial of Human Papillomavirus Test-and-Treat as Compared to Cytology-Based Screening for Prevention of Cervical Cancer Among Women With Human Immunodeficiency Virus: AIDS Clinical Trials Group Protocol A5282. Wilkin T; Chen H; Sahasrabuddhe V; Matining R; Mngqibisa R; Chinula L; Mbilizi Y; Magure T; Omoz-Oarhe AE; Rassool M; Riviere C; Bhosale R; Godbole S; Naranjo R; Coombs R; Michelow P; Godfrey C; Firnhaber C Clin Infect Dis; 2022 Oct; 75(8):1280-1288. PubMed ID: 35294524 [TBL] [Abstract][Full Text] [Related]
10. Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program. Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B BMC Cancer; 2016 Nov; 16(1):835. PubMed ID: 27809810 [TBL] [Abstract][Full Text] [Related]
11. Understanding the Acceptability and Uptake of HPV Self-Sampling Amongst Women Under- or Never-Screened for Cervical Cancer in Toronto (Ontario, Canada): An Intervention Study Protocol. Lofters A; Devotta K; Prakash V; Vahabi M Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501703 [TBL] [Abstract][Full Text] [Related]
12. ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening. Kitchener HC; Almonte M; Gilham C; Dowie R; Stoykova B; Sargent A; Roberts C; Desai M; Peto J; Health Technol Assess; 2009 Nov; 13(51):1-150, iii-iv. PubMed ID: 19891902 [TBL] [Abstract][Full Text] [Related]
13. Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment: A Randomized Clinical Trial. Winer RL; Lin J; Tiro JA; Miglioretti DL; Beatty T; Gao H; Kimbel K; Thayer C; Buist DSM JAMA Netw Open; 2019 Nov; 2(11):e1914729. PubMed ID: 31693128 [TBL] [Abstract][Full Text] [Related]
14. Cervical Cancer Screening with Human Papillomavirus Self-Sampling Among Transgender Men in El Salvador. Maza M; Meléndez M; Herrera A; Hernández X; Rodríguez B; Soler M; Alfaro K; Masch R; Conzuelo-Rodríguez G; Obedin-Maliver J; Cremer M LGBT Health; 2020; 7(4):174-181. PubMed ID: 32407149 [No Abstract] [Full Text] [Related]
15. Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia. Sultana F; English DR; Simpson JA; Brotherton JM; Drennan K; Mullins R; Heley S; Wrede CD; Saville M; Gertig DM BMC Cancer; 2014 Mar; 14():207. PubMed ID: 24646201 [TBL] [Abstract][Full Text] [Related]
16. Non-speculum clinician-taken samples for human papillomavirus testing: a cross-sectional study in older women. Landy R; Hollingworth T; Waller J; Marlow LA; Rigney J; Round T; Sasieni PD; Lim AW Br J Gen Pract; 2022 Aug; 72(721):e538-e545. PubMed ID: 35667684 [TBL] [Abstract][Full Text] [Related]
17. Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial. Fujita M; Nagashima K; Shimazu M; Suzuki M; Tauchi I; Sakuma M; Yamamoto S; Hanaoka H; Shozu M; Tsuruoka N; Kasai T; Hata A PLoS One; 2023; 18(6):e0286909. PubMed ID: 37289798 [TBL] [Abstract][Full Text] [Related]
18. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial. Lilliecreutz C; Karlsson H; Spetz Holm AC PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the effectiveness of high-risk human papilloma self-sampling test for cervical cancer screening in Bolivia. Allende G; Surriabre P; Ovando N; Calle P; Torrico A; Villarroel J; Bossens M; Fontaine V; Rodriguez P BMC Infect Dis; 2020 Apr; 20(1):259. PubMed ID: 32245369 [TBL] [Abstract][Full Text] [Related]
20. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial. Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]